Science Explorer Back to mapMap

Most cited papers from ReproCELL (United States)

What are the most cited papers from ReproCELL (United States)?

The most cited paper from ReproCELL (United States) is "Octamer and Sox Elements Are Required for Transcriptional cis Regulation of Nanog Gene Expression" (Takao Kuroda, Masako Tada, HIROSHI Y. KUBOTA et al., 2005), with 495 citations. Next come "The Epstein Barr virus circRNAome" (156) and "Wnt Inhibition Facilitates RNA-Mediated Reprogramming of Human Somatic Cells to Naive Pluripotency" (122).

Showing 12 of 12 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Octamer and Sox Elements Are Required for Transcriptional cis Regulation of Nanog Gene Expression Takao Kuroda, Masako Tada, HIROSHI Y. KUBOTA et al. · Molecular and Cellular Biology Open access Mar 2005 495
2 The Epstein Barr virus circRNAome Nathan Ungerleider, Monica Concha, Zhen Nan Lin et al. · PLoS Pathogens Open access 6 Aug 2018 156
3 Wnt Inhibition Facilitates RNA-Mediated Reprogramming of Human Somatic Cells to Naive Pluripotency Nicholas Bredenkamp, Jian Ping Yang, James D. Clarke et al. · Stem Cell Reports Open access 7 Nov 2019 122
4 Comparative Analysis of Gammaherpesvirus Circular RNA Repertoires: Conserved and Unique Viral Circular RNAs Nathan Ungerleider, Vaibhav Jain, Yiping Wang et al. · Journal of Virology Open access 18 Dec 2018 82
5 Characterization of human iPSC-derived sensory neurons and their functional assessment using multi electrode array Minami Hiranuma, Yuichi Okuda, Yuuka Fujii et al. · Scientific Reports Open access 12 Mar 2024 25
6 Mutational landscape of BRCA gene mutations in Indian breast cancer patients: retrospective insights from a diagnostic lab Rosy Chikkala, Deepak Bhayal, Nikki Rani et al. · Egyptian Journal of Medical Human Genetics Open access 5 Sep 2024 6
7 Clinically compatible advances in blood-derived endothelial progenitor cell isolation and reprogramming for translational applications Sarah Eminli, Baraa Kwieder, Kevin Yi et al. · New Biotechnology 15 Feb 2021 6
8 The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer carrying otherwise therapy-refractory mutations Aditya Vitthal Kulkarni, Joseph Ryan McDermott, Umesh Kathad et al. · Oncotarget Open access 8 Apr 2021 4
9 Generation of Human iPSCs by Reprogramming with the Unmodified Synthetic mRNA R. R. Annand · Methods in molecular biology Book chapter 23 Nov 2020 3
10 "Nuclear Reprogramming" and "Epigenetic Reprogramming" Takashi Tada, Hironobu Kimura, Masako Tada · Journal of Mammalian Ova Research Open access 2004 1
11 Muscarinic receptor blockade with oxybutynin reduces spontaneous and induced uterine muscle contractions Anthony G. Visco, Zachary R. Visco, Chad A. Grotegut et al. · Pregnancy Open access 2025 0
12 Human iPS cell-derived cardiomyocytes ReproCardio 2™ as an analytic tool for large-scale toxicity screening Shunsuke Yoshida, Yu Ching Lin, Joylynn Clark et al. · Journal of Pharmacological and Toxicological Methods Sep 2015 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.